FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315652711> ?p ?o ?g. }

• W4315652711 endingPage "104508" @default.
• W4315652711 startingPage "104508" @default.
• W4315652711 abstract "This study describes the therapeutic strategies in NMOSD and MOGAD adopted by neurologists to treat both conditions in Latin America (LATAM) with main focus on rituximab (RTX) and the disease outcome.retrospective study in a cohort of NMOSD and MOGAD patients followed in specialized MS/NMOSD centers from eight countries and 14 LATAM reference centers. Demographics and clinical characteristics were collected. RTX strategies on naïve (for rituximab) patients were summarized as follows: scheme A: two 1000 mg infusions 15 days apart and repeated every 6 months; scheme B: four 375 mg/m2 infusions every week for 4 weeks and repeated every 6 months; scheme C: one 1000 mg infusions and repeated every 6 months; scheme D: other scheme used. Relapse rate and adverse events during follow-up were analyzed considering the different RTX schemes. Poisson and logistic regression analysis were used to assess baseline aspects and disease activity during follow-up.A total of 217 patients were included. 197 were NMOSD patients (164, 83.2% AQP4-IgG seropositive and 16.7% seronegative) and 20 were MOGAD patients. The most frequent long-term treatment was RTX in both groups (48.2% and 65% for NMOSD and MOGAD patients, respectively). The most common RTX regimen used in 79 (83.1%) patients was two 1000 mg infusions 15 days apart and repeat every 6 months. Relapses under RTX treatment were observed in 21 (22.1%) patients. Relapses after RTX treatment were associated with higher EDSS (OR 1.75, 95%CI 1.44-2.34, p = 0.03) and higher ARR pre-RTX (OR = 2.17, 95% CI 1.72-3.12, p = 0.002) but not with RTX regimen (OR = 1.10, 95% CI 0.89-1.21, p = 0.60).the most strategy used in LATAM was RTX with two 1000 mg infusions 15 days apart. Relapses during follow up were not associated with RTX regimen used." @default.
• W4315652711 created "2023-01-12" @default.
• W4315652711 creator A5002445283 @default.
• W4315652711 creator A5003786201 @default.
• W4315652711 creator A5004456380 @default.
• W4315652711 creator A5008156550 @default.
• W4315652711 creator A5010121007 @default.
• W4315652711 creator A5011764672 @default.
• W4315652711 creator A5017570256 @default.
• W4315652711 creator A5021719700 @default.
• W4315652711 creator A5022222759 @default.
• W4315652711 creator A5022666378 @default.
• W4315652711 creator A5023804532 @default.
• W4315652711 creator A5024894950 @default.
• W4315652711 creator A5027171153 @default.
• W4315652711 creator A5028534134 @default.
• W4315652711 creator A5029600939 @default.
• W4315652711 creator A5029651525 @default.
• W4315652711 creator A5034681390 @default.
• W4315652711 creator A5036236307 @default.
• W4315652711 creator A5042670252 @default.
• W4315652711 creator A5047365609 @default.
• W4315652711 creator A5048279797 @default.
• W4315652711 creator A5056464427 @default.
• W4315652711 creator A5057568885 @default.
• W4315652711 creator A5058556547 @default.
• W4315652711 creator A5061601798 @default.
• W4315652711 creator A5082131396 @default.
• W4315652711 creator A5082829972 @default.
• W4315652711 creator A5088128007 @default.
• W4315652711 creator A5088648518 @default.
• W4315652711 date "2023-03-01" @default.
• W4315652711 modified "2023-10-01" @default.
• W4315652711 title "Therapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America" @default.
• W4315652711 cites W2035786794 @default.
• W4315652711 cites W2038941725 @default.
• W4315652711 cites W2106131489 @default.
• W4315652711 cites W2120238028 @default.
• W4315652711 cites W2129229339 @default.
• W4315652711 cites W2155112931 @default.
• W4315652711 cites W2893232755 @default.
• W4315652711 cites W2903897726 @default.
• W4315652711 cites W2978733041 @default.
• W4315652711 cites W2999095672 @default.
• W4315652711 cites W3012376934 @default.
• W4315652711 cites W3113007771 @default.
• W4315652711 cites W3164850234 @default.
• W4315652711 cites W3166273159 @default.
• W4315652711 cites W3178845281 @default.
• W4315652711 cites W3199078545 @default.
• W4315652711 cites W4224033419 @default.
• W4315652711 cites W4293843069 @default.
• W4315652711 doi "https://doi.org/10.1016/j.msard.2023.104508" @default.
• W4315652711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36738691" @default.
• W4315652711 hasPublicationYear "2023" @default.
• W4315652711 type Work @default.
• W4315652711 citedByCount "0" @default.
• W4315652711 crossrefType "journal-article" @default.
• W4315652711 hasAuthorship W4315652711A5002445283 @default.
• W4315652711 hasAuthorship W4315652711A5003786201 @default.
• W4315652711 hasAuthorship W4315652711A5004456380 @default.
• W4315652711 hasAuthorship W4315652711A5008156550 @default.
• W4315652711 hasAuthorship W4315652711A5010121007 @default.
• W4315652711 hasAuthorship W4315652711A5011764672 @default.
• W4315652711 hasAuthorship W4315652711A5017570256 @default.
• W4315652711 hasAuthorship W4315652711A5021719700 @default.
• W4315652711 hasAuthorship W4315652711A5022222759 @default.
• W4315652711 hasAuthorship W4315652711A5022666378 @default.
• W4315652711 hasAuthorship W4315652711A5023804532 @default.
• W4315652711 hasAuthorship W4315652711A5024894950 @default.
• W4315652711 hasAuthorship W4315652711A5027171153 @default.
• W4315652711 hasAuthorship W4315652711A5028534134 @default.
• W4315652711 hasAuthorship W4315652711A5029600939 @default.
• W4315652711 hasAuthorship W4315652711A5029651525 @default.
• W4315652711 hasAuthorship W4315652711A5034681390 @default.
• W4315652711 hasAuthorship W4315652711A5036236307 @default.
• W4315652711 hasAuthorship W4315652711A5042670252 @default.
• W4315652711 hasAuthorship W4315652711A5047365609 @default.
• W4315652711 hasAuthorship W4315652711A5048279797 @default.
• W4315652711 hasAuthorship W4315652711A5056464427 @default.
• W4315652711 hasAuthorship W4315652711A5057568885 @default.
• W4315652711 hasAuthorship W4315652711A5058556547 @default.
• W4315652711 hasAuthorship W4315652711A5061601798 @default.
• W4315652711 hasAuthorship W4315652711A5082131396 @default.
• W4315652711 hasAuthorship W4315652711A5082829972 @default.
• W4315652711 hasAuthorship W4315652711A5088128007 @default.
• W4315652711 hasAuthorship W4315652711A5088648518 @default.
• W4315652711 hasConcept C126322002 @default.
• W4315652711 hasConcept C141071460 @default.
• W4315652711 hasConcept C167135981 @default.
• W4315652711 hasConcept C187212893 @default.
• W4315652711 hasConcept C203014093 @default.
• W4315652711 hasConcept C2779338263 @default.
• W4315652711 hasConcept C2780640218 @default.
• W4315652711 hasConcept C2780653079 @default.
• W4315652711 hasConcept C2781413609 @default.
• W4315652711 hasConcept C71924100 @default.
• W4315652711 hasConcept C72563966 @default.

• next